PharmaCielo Ltd. PCLOF OTC

PharmaCielo Ltd. (PCLOF) generated $-881.18K in operating cash flow for fiscal year 2025. After capital expenditures of $4.00, free cash flow was $-881.18K.

Free cash flow margin was -33.9% of revenue. Cash conversion ratio was -2.16x, suggesting some earnings are non-cash.

Criteria supported by this page:

• HEALTH (0/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (29/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (10/100) — Cash conversion ratio was -2.16x suggests some earnings are non-cash items

Overall SharesGrow Score: 23/100 with 1/7 criteria passed.